531592 — Genpharmasec Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual income statement for Genpharmasec, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	213	273	255	304	337
Cost of Revenue
Gross Profit	21.1	7.55	21.2	61.7	41.7
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	201	279	253	304	345
Operating Profit	11.8	-5.36	2.37	0.039	-7.47
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	15.1	-4.43	2.82	2.51	18.8
Provision for Income Taxes
Net Income After Taxes	12.6	-2.09	11.2	-1.69	12.3
Minority Interest
Net Income Before Extraordinary Items
Net Income	12.6	-2.09	11.2	-1.26	12.3
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	12.6	-2.09	11.2	-1.26	12.3
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.027	-0.005	0.024	-0.004	0.022